Major abortion pill maker GenBioPro hires its first lobbyists in Washington

WASHINGTON – GenBioPro, which sells the generic version of the abortion pill mifepristone, hired its own team of lobbyists for the first time this summer, according to new federal disclosures.

GenBioPro has hired two lobbyists from the firm Emergent Strategies to advocate on “Issues related to medication abortion … abortion access [and] FDA Approval of Mifepristone,” its filing states. Emergent officially registered to represent GenBioPro on July 11.

GenBioPro is one of just two companies in the United States that makes these pills, which terminate a pregnancy by blocking the pregnancy hormone progesterone.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In